Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors

Details for Australian Patent Application No. 2005240785 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Buyck, Christophe, Francis, Robert, Nestor; Van Der Veken, Louis, Jozef, Elisabeth; Jaroskova, Libuse; Linders, Joannes, Theodorus, Maria

Agent Shelston IP

Pub. Number AU-B-2005240785

PCT Pub. Number WO2005/108361

Priority 04101993.6 07.05.04 EP

Filing date 29 April 2005

Wipo publication date 17 November 2005

Acceptance publication date 3 February 2011

International Classifications

C07D 207/267 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/76 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 453/06 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/108361 Priority application(s): WO2005/108361

3 February 2011 Application Accepted

  Published as AU-B-2005240785

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240816-6-substituted pyridoindolone derivatives production and therapeutic use thereof

2005240784-Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors